Mark Lackner, SVP, Head of Biology at IDEAYA Biosciences, holds 195.73K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 0.00 shares in IDEAYA Biosciences (Ticker: IDYA).
What is the percentage of profitable transactions made by Mark Lackner?
The percentage of profitable transactions made by Mark Lackner is ―.
What is the average return per transaction made by Mark Lackner?
The average return per transaction made by Mark Lackner is ―.
What stocks does Mark Lackner hold?
Mark Lackner holds: IDYA, ZNTL stocks.
What was Mark Lackner’s latest transaction?
Mark Lackner latest transaction was an Uninformative Buy of ―.
What was Mark Lackner's most profitable transaction?
Mark Lackner’s most profitable transaction was an Informative Sell of ZNTL stock on February 5, 2024. The return on the trade was 70.70%.
What is Mark Lackner's role in IDEAYA Biosciences?
Mark Lackner's role in IDEAYA Biosciences is SVP, Head of Biology.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.